See also this year's filing and all EDGAR filings for this company.
PDF Report 0001347242_2023_Lipella_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001347242, Lipella Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,799,289 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 150,821 |
| 4 | LiabilitiesCurrent | 1,178,256 |
| 5 | LiabilitiesNoncurrent | 96,258 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 226,192 |
| 9 | ResearchAndDevelopmentExpense | 2,547,677 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 184,156 |
| 12 | remainder_NetIncome | -7,979 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,950,110 |
| 1 | Liabilities | 1,274,514 |
| 2 | Expenses | 2,773,869 |
| 3 | Revenues | 184,156 |
| 4 | StockholdersEquity | 4,675,596 |
| 5 | NetIncome | -2,597,692 |
| 6 | ComprehensiveNetIncome | -2,597,692 |
| 7 | BaseVar | 5,095,314 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.10 |
| 9 | EconomicCapitalRatio | 3.09 |
Edgar->Model Mapping
Feature Distribution
